Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Paclitaxel|DRUG: Capecitabine
Sponsor: Providence Health & Services
Collaborators: Merck Sharp & Dohme LLC